DK3134105T3 - Peptidanaloger med én eller flere forgrenede aminosyreprober - Google Patents

Peptidanaloger med én eller flere forgrenede aminosyreprober Download PDF

Info

Publication number: DK3134105T3
Authority: DK; Denmark
Prior art keywords: amino acid; branched chain; chain amino; acid probes; peptide analogs
Prior art date: 2014-04-22

Application number

DK15734720.4T

Other languages

English (en)

Inventor

Thomas Boesen

Original Assignee

Txp Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-04-22

Filing date

2015-04-21

Publication date

2021-02-22

2015-04-21 Application filed by Txp Pharma Gmbh filed Critical Txp Pharma Gmbh

2021-02-22 Application granted granted Critical

2021-02-22 Publication of DK3134105T3 publication Critical patent/DK3134105T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Toxicology (AREA)
Obesity (AREA)
Rheumatology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Neurosurgery (AREA)
Neurology (AREA)

DK15734720.4T 2014-04-22 2015-04-21 Peptidanaloger med én eller flere forgrenede aminosyreprober DK3134105T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201461982709P	2014-04-22	2014-04-22
PCT/IB2015/000553 WO2015162485A1 (en)	2014-04-22	2015-04-21	Peptide analogues with branched amino acid probe(s)

Publications (1)

Publication Number	Publication Date
DK3134105T3 true DK3134105T3 (da)	2021-02-22

Family

ID=53524914

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK15734720.4T DK3134105T3 (da)	2014-04-22	2015-04-21	Peptidanaloger med én eller flere forgrenede aminosyreprober

Country Status (12)

Country	Link
US (3)	US9950027B2 (da)
EP (2)	EP3838285A1 (da)
JP (2)	JP2017513875A (da)
CN (1)	CN106232623A (da)
AU (1)	AU2015249540B2 (da)
BR (1)	BR112016024494B1 (da)
CA (1)	CA2943458C (da)
DK (1)	DK3134105T3 (da)
ES (1)	ES2854353T3 (da)
HU (1)	HUE052977T2 (da)
RU (1)	RU2016142145A (da)
WO (1)	WO2015162485A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2668791C2 (ru)	2012-10-19	2018-10-02	ТиЭксПи ФАРМА ГМБХ	АНАЛОГИ АЛЬФА- и ГАММА-MSH
JP2017513875A (ja) *	2014-04-22	2017-06-01	ティーエックスピーファーマゲゼルシャフトミットベシュレンクテルハフツング	分枝状アミノ酸プローブを有するペプチド類似体
TWI715755B (zh) *	2016-05-02	2021-01-11	愛爾蘭商滿捷特科技公司	用於高速列印之單色噴墨列印頭
RU2678987C2 (ru) *	2017-04-28	2019-02-05	Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА"	Пептид для лечения болезни альцгеймера
NZ766762A (en) *	2018-01-31	2026-03-27	Sanofi Sa	Modified lipidated relaxin b chain peptides and their therapeutic use
CN108395484A (zh) *	2018-03-15	2018-08-14	华东理工大学	支链氨基酸荧光探针及其应用
CN109232747B (zh) *	2018-09-26	2019-06-11	哈尔滨工业大学	强啡肽a(1-8)与神经降压素(8-13)相偶联的环化杂合肽及其合成方法和应用
CN109283341A (zh) *	2018-10-17	2019-01-29	北京市心肺血管疾病研究所	一组预测心肌梗死患者的pci术后预后的生物标志物
WO2020198604A1 (en) *	2019-03-28	2020-10-01	United States Government As Represented By The Department Of Veterans Affairs	Compositions and methods of treating and preventing systemic complications of acute illness
CN110456074B (zh) *	2019-08-27	2022-06-03	广东菲鹏生物有限公司	瓜氨酸肽及其应用、类风湿关节炎的检测试剂与试剂盒
WO2022034062A1 (en)	2020-08-12	2022-02-17	Txp Pharma Ag	Exendin-4 peptide analogues
PL4200319T3 (pl)	2020-08-21	2025-08-18	Resother Pharma A/S	Preparaty peptydu n-końcowego aneksyny a1 i sposoby
WO2022159555A1 (en) *	2021-01-20	2022-07-28	The Trustees Of Columbia University In The City Of New York	Methods for treating graft-versus-host disease using glp-2 agonists and analogues thereof
CA3219053A1 (en) *	2021-05-05	2022-11-10	Arcturus Therapeutics, Inc.	Lipid compositions comprising peptide-lipid conjugates
CN113238060B (zh) *	2021-05-08	2022-10-11	迈克生物股份有限公司	用于预测或诊断心肌炎的试剂盒
CN118891273A (zh)	2022-02-23	2024-11-01	雷索特制药股份有限公司	膜联蛋白a1衍生的多肽类似物
CN115925784B (zh) *	2022-11-24	2023-06-09	北京工商大学	一种丹磺酰类铜离子荧光探针、制备方法及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4166452A (en)	1976-05-03	1979-09-04	Generales Constantine D J Jr	Apparatus for testing human responses to stimuli
US4356108A (en)	1979-12-20	1982-10-26	The Mead Corporation	Encapsulation process
US4265874A (en)	1980-04-25	1981-05-05	Alza Corporation	Method of delivering drug with aid of effervescent activity generated in environment of use
US5597894A (en) *	1995-06-05	1997-01-28	The Louisiana State University Medical Center Foundation	Multi-tyrosinated somatostatin analogs
JP2001506996A (ja)	1996-12-17	2001-05-29	クアドラントホールディングスケンブリッジリミテッド	メラノコルチン受容体３、４又は５の特異結合のためのメラノコルチン誘導体
NZ506839A (en) *	1998-03-09	2003-05-30	Zealand Pharma As	Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
SE9801571D0 (sv)	1998-05-05	1998-05-05	Wapharm Ab	Melanokortin-1-receptorselektiva föreningar
DE69941510D1 (de) *	1998-08-10	2009-11-19	Us Gov Nat Inst Health	Differenzierung von nicht-insulin in insulin-produzierende zellen durch glp-1 und exendin-4 und dessen verwendung
AU7593001A (en)	2000-07-14	2002-01-30	Zycos Inc	Alpha-msh related compounds and methods of use
ATE549028T1 (de) *	2003-05-15	2012-03-15	Tufts College	Stabile analoga von glp-1
US7169303B2 (en)	2003-05-28	2007-01-30	Hemocleanse Technologies, Llc	Sorbent reactor for extracorporeal blood treatment systems, peritoneal dialysis systems, and other body fluid treatment systems
US8912144B2 (en)	2003-12-16	2014-12-16	Children's Medical Center Corporation	Method for treating stroke via administration of NEP1-40 and inosine
NZ565217A (en)	2005-07-08	2010-03-26	Ipsen Pharma Sas	Melanocortin receptor ligands
CN101273059B (zh) *	2005-08-26	2014-02-19	艾伯维有限公司	治疗活性的α-MSH类似物
US8507428B2 (en) *	2010-12-22	2013-08-13	Indiana University Research And Technology Corporation	Glucagon analogs exhibiting GIP receptor activity
RU2668791C2 (ru)	2012-10-19	2018-10-02	ТиЭксПи ФАРМА ГМБХ	АНАЛОГИ АЛЬФА- и ГАММА-MSH
CN103536912B (zh) *	2013-09-30	2015-05-13	重庆理工大学	一种猪圆环病毒2型表位肽疫苗及其制备方法
JP2017513875A (ja) *	2014-04-22	2017-06-01	ティーエックスピーファーマゲゼルシャフトミットベシュレンクテルハフツング	分枝状アミノ酸プローブを有するペプチド類似体
WO2015162486A1 (en)	2014-04-22	2015-10-29	Txp Pharma Gmbh	Linear gamma msh with c- and / or n-terminal extensions of lysine and / or glutamic acid residues
WO2015162483A1 (en)	2014-04-22	2015-10-29	Txp Pharma Gmbh	Alpha- and gamma-msh analogues

2015
- 2015-04-21 JP JP2016563917A patent/JP2017513875A/ja active Pending
- 2015-04-21 DK DK15734720.4T patent/DK3134105T3/da active
- 2015-04-21 ES ES15734720T patent/ES2854353T3/es active Active
- 2015-04-21 CN CN201580020722.6A patent/CN106232623A/zh active Pending
- 2015-04-21 RU RU2016142145A patent/RU2016142145A/ru not_active Application Discontinuation
- 2015-04-21 BR BR112016024494-0A patent/BR112016024494B1/pt active IP Right Grant
- 2015-04-21 HU HUE15734720A patent/HUE052977T2/hu unknown
- 2015-04-21 CA CA2943458A patent/CA2943458C/en active Active
- 2015-04-21 EP EP20207741.8A patent/EP3838285A1/en active Pending
- 2015-04-21 AU AU2015249540A patent/AU2015249540B2/en active Active
- 2015-04-21 EP EP15734720.4A patent/EP3134105B8/en active Active
- 2015-04-21 WO PCT/IB2015/000553 patent/WO2015162485A1/en not_active Ceased
- 2015-04-22 US US14/693,810 patent/US9950027B2/en active Active
2018
- 2018-03-09 US US15/917,223 patent/US11141455B2/en active Active
2020
- 2020-06-24 JP JP2020109088A patent/JP7253812B2/ja active Active
2021
- 2021-09-09 US US17/470,310 patent/US20220133839A1/en active Pending

Also Published As

Publication number	Publication date
US11141455B2 (en)	2021-10-12
EP3134105B8 (en)	2020-12-30
CA2943458C (en)	2025-05-13
EP3838285A1 (en)	2021-06-23
CN106232623A (zh)	2016-12-14
RU2016142145A (ru)	2018-05-22
ES2854353T3 (es)	2021-09-21
JP2020172496A (ja)	2020-10-22
RU2016142145A3 (da)	2018-12-12
EP3134105B1 (en)	2020-11-18
WO2015162485A1 (en)	2015-10-29
EP3134105A1 (en)	2017-03-01
AU2015249540B2 (en)	2019-08-22
JP2017513875A (ja)	2017-06-01
BR112016024494A2 (pt)	2017-08-15
BR112016024494A8 (pt)	2021-07-06
BR112016024494B1 (pt)	2024-02-06
US20220133839A1 (en)	2022-05-05
CA2943458A1 (en)	2015-10-29
US20190030115A1 (en)	2019-01-31
US9950027B2 (en)	2018-04-24
HUE052977T2 (hu)	2021-06-28
JP7253812B2 (ja)	2023-04-07
US20150297671A1 (en)	2015-10-22
AU2015249540A1 (en)	2016-11-17

Publication	Publication Date	Title
DK3134105T3 (da)	2021-02-22	Peptidanaloger med én eller flere forgrenede aminosyreprober
EP3370731A4 (en)	2019-06-12	nucleotide analogs
IL254516B (en)	2021-10-31	Proteins specific for cd137
EP3362556C0 (en)	2024-07-10	POLYPEPTIDE VARIANTS
EP3305649A4 (en)	2019-07-31	SHIP
EP3375704A4 (en)	2019-06-19	SHIP
DK3182985T3 (da)	2020-04-06	Fibroinafledt proteinsammensætning
DK3194411T3 (da)	2022-05-30	Nukleotidanaloger
IL251571A0 (en)	2017-06-29	Variable proteins comprising the cry1da1 amino acid sequence are activated by lepidopteran
LT3160952T (lt)	2021-05-10	Histono demetilazės inhibitoriai
EP3350191A4 (en)	2019-03-20	nucleotide analogs
DK3310340T3 (da)	2025-12-15	Formulering med høj koncentration
EP3294281A4 (en)	2019-01-23	AMINOSÄURESUPPLMENTIERUNG
DK3102195T3 (da)	2021-12-20	Beta-substituerede beta-aminosyrer og analoger som kemoterapeutiske midler
DK3364189T3 (da)	2021-03-22	Immunkromatografisk teststykke
EP2976353A4 (en)	2016-02-10	Autophagy-inducing peptide analogs
EP4027134C0 (en)	2024-01-10	INSPECTION SYSTEM
EP3328438A4 (en)	2019-02-27	POLYPEPTIDE MONOLITH
HRP20182029T1 (hr)	2019-02-08	Uti-fuzijski proteini
DK3207052T3 (da)	2020-11-16	Biosensor baseret på gbetagamma-interagerende proteiner til at monitorere g-proteinaktivering
DK3137494T3 (da)	2021-10-04	Isletamyloidpolypeptider med forbedret opløselighed
EP4040214C0 (en)	2025-03-12	INSPECTION KIT
DK3402573T3 (da)	2023-05-30	Aminosyreholdig sammensætning
HUE042119T2 (hu)	2019-06-28	Aminoészter-származékok
DK3560348T3 (da)	2024-01-15	Aminosyredrik med allulose